Yeow Tee Goh

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Dna Methylation

Tyrosine Kinase

Chronic Myeloid Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science advances

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun, Li Jia, Benedict Yan, Alvin Yu-Jin Ng, Sharah Mae Capinpin, Renwei Wang, Ying Li, Wee-Joo Chng, H Phillip Koeffler, Woon-Puay Koh, Woon Puay Koh, Henry Yang, Yeow Tee Goh, Nicholas Francis Grigoropoulos
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun, Li Jia, Benedict Yan, Alvin Yu-Jin Ng, Sharah Mae Capinpin, Renwei Wang, Ying Li, Wee-Joo Chng, H Phillip Koeffler, Woon-Puay Koh, Woon Puay Koh, Henry Yang, Yeow Tee Goh, Nicholas Francis Grigoropoulos
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun, Li Jia, Benedict Yan, Alvin Yu-Jin Ng, Sharah Mae Capinpin, Renwei Wang, Ying Li, Wee-Joo Chng, H Phillip Koeffler, Woon-Puay Koh, Woon Puay Koh, Henry Yang, Yeow Tee Goh, Nicholas Francis Grigoropoulos
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun, Li Jia, Benedict Yan, Alvin Yu-Jin Ng, Sharah Mae Capinpin, Renwei Wang, Ying Li, Wee-Joo Chng, H Phillip Koeffler, Woon-Puay Koh, Woon Puay Koh, Henry Yang, Yeow Tee Goh, Nicholas Francis Grigoropoulos
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Raymond S M Wong, Juan Ramon Navarro-Cabrera, Narcisa Sonia Comia, Yeow Tee Goh, Henry Idrobo, Daolada Kongkabpan, David Gómez-Almaguer, Mohammed Al-Adhami, Temitayo Ajayi, Paulo Alvarenga, Jessica Savage, Pascal Deschatelets, Cedric G Francois, Federico V Grossi, Teresita Ellarda Dumagay
Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria. Blood advances (2023)
Jeremy Wee Kiat Ng, Kar Wai Tan, Dian Yan Guo, Joey Jia Hui Lai, Xiubo Fan, Zhiyong Poon, Tse Hui Lim, Alvin Soon Tiong Lim, Tony Kiat Hon Lim, William Ying Khee Hwang, Shang Li, Connie J Eaves, Yeow Tee Goh, Alice Man Sze Cheung
Cord blood-derived V δ 2 + and V δ 2 - T cells acquire differential cell state compositions upon in vitro expansion. Science advances 9 (24) (2023)
Zhentang Lao, Eric Wai Choi Tse, Suporn Chuncharunee, Yok Lam Kwong, Andrew Wei, Bor Sheng Ko, Jin Seok Kim, Soo Chin Ng, Jianxiang Wang, Yeow Tee Goh
Asia-Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia-Pacific region. Asia-Pacific journal of clinical oncology (2023)
Eric Wai-Choi Tse, Yok Lam Kwong, Yeow Tee Goh, Ping Chong Bee, Soo Chin Ng, Daryl Tan, Priscilla Caguioa, Huynh Nghia, Teresita Dumagay, Lalita Norasetthada, Suporn Chuncharunee, Radhakrishnan Vs, Bhausaheb Pandurang Bagal, Tubagus Djumhana Atmakusuma, Nadia Ayu Mulansari
Expert consensus on the management of chronic lymphocytic leukaemia in Asia. Clinical and experimental medicine (2023)
Michael J Mauro, Timothy P Hughes, Dong-Wook Kim, Delphine Rea, Jorge E Cortes, Andreas Hochhaus, Koiji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J DeAngelo, Michael C Heinrich, Valle Gómez-García de Soria, Philipp le Coutre, Francois-Xavier Mahon, Jeroen J W M Janssen, Michael Deininger, Naranie Shanmuganathan, Mark Blaine Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results. Leukemia (2023)
Samer K Khaled, Kathleen J Claes, Yeow Tee Goh, Yok Lam Kwong, Nelson R Leung, Włodzimierz Mendrek, Ryotaro Nakamura, Jameela Sathar, Edmund Ng, Narinder Nangia, Steve Whitaker, Alessandro Rambaldi, null null
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Yunxin Chen, Sathish Kumar Gopalakrishnan, Melissa Ooi, Rehena Sultana, Li Hui Lim, Nicholas Francis Grigoropoulos, Shin Yeu Ong, Mingge Xu, null null, Wee-Joo Chng, Yeow Tee Goh, Chandramouli Nagarajan
A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1). Blood cancer journal 11 (9) (2021)